Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Puma Biotechnology Inc. buy blaugold

Start price
€2.87
21.11.21 / 50%
Target price
-
21.11.22
Performance (%)
-0.24%
End price
€2.86
27.11.21
Summary
This prediction ended on 27.11.21 with a price of €2.86. During the runtime of the prediction for Puma Biotechnology Inc. the price only changed by -0.24%. blaugold has a follow-up prediction for Puma Biotechnology Inc. where he still thinks Puma Biotechnology Inc. is a Buy. blaugold has 50% into this prediction

Puma Biotechnology is a publicly traded biopharmaceutical company that develops innovative cancer therapies targeting the most aggressive and difficult-to-treat forms of the disease. Puma's lead product is Nerlynx, an oral medication approved for the treatment of HER2-positive breast cancer, and the company also has a number of other promising drugs in its pipeline. Founded in 2010, Puma is headquartered in Los Angeles, California, and its shares trade on the NASDAQ exchange under the ticker symbol PBYI.

Performance without dividends (%)
Name 1w 1m 1y
Puma Biotechnology Inc. 20.465% 20.465% 134.495%
iShares Core DAX® 2.149% 5.415% 21.385%
iShares Nasdaq 100 0.838% 1.926% 44.386%
iShares Nikkei 225® 1.143% 2.887% 27.641%
iShares S&P 500 1.265% 3.698% 33.327%

Comments by blaugold for this prediction

In the thread Puma Biotechnology Inc. diskutieren

Buy Puma Biotechnology Inc.

In the thread Trading Puma Biotechnology Inc.
Prediction Buy
Perf. (%) -0.24%
Target price
Change
Ends at 21.11.22

Buy beendet

Current prediction by blaugold for Puma Biotechnology Inc.

buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€3.95
19.03.24
-
19.03.25
31.14%
26.03.24

Stopped prediction by blaugold for Puma Biotechnology Inc.

buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€8.82
07.08.20
€10.00
10.08.20
-0.32%
10.08.20

buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€7.96
08.10.19
€10.00
14.10.19
-20.97%
14.10.19